Abraham Owusu Dommey, MD
Internal Medicine · Gilbert, AZNPI 1457311367
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 32.0% of the total. Reporting peaked in 2024 at $236 and has fallen 57.0% since, to $101 in 2025.
Across 30 payments — averaging $25.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$247
- Avinger Inc.$125
- Smith+Nephew$119
- Melinta Therapeutics, LLC$60
- Boston Scientific$39
- Solventum Corporation$32
- plus $150 from 8 others
What the payments were for
- Food & beverage$773100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 7 | $247 |
| Avinger Inc. | 1 | $125 |
| Smith+Nephew | 8 | $119 |
| Melinta Therapeutics, LLC | 4 | $60 |
| Boston Scientific | 1 | $39 |
| Solventum Corporation | 1 | $32 |
| Mimedx Group, Inc. | 1 | $30 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Misonix Inc | 1 | $20 |
| Organogenesis Inc. | 1 | $18 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $15 |
| KCI USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$773 in reported general payments places this provider in the 70th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $10,911 |
| Gentamicin Sulfate | 35 | $1,990 |
| Doxycycline Hyclate | 46 | $756 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $669 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $471 |
| Nystatin | 22 | $444 |
| Mupirocin | 18 | $256 |
| Gabapentin | 21 | $198 |
| Famotidine | 21 | $181 |
| Ciprofloxacin Hcl | 15 | $175 |
| Losartan Potassium | 19 | $155 |
| Cephalexin | 11 | $135 |
| ClopidogrelClopidogrel Bisulfate | 20 | $128 |
| Atorvastatin Calcium | 26 | $127 |
| SsdSilver Sulfadiazine | 16 | $99 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Gilbert
- Abhimanyu GhoseGilbert$73K
- Wishwdeep DhillonGilbert$25K
- Kelli FavataGilbert$14K
- Frank LovecchioPhoenix$911K
- Nasser HajaigPhoenix$687K
- Rajesh JanardhananTucson$685K
- Mona SelejTucson$440K
- Kelly KrohnPhoenix$262K
- Jacque SokolovScottsdale$235K
- Paul StanderPhoenix$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.